Long-term persistance of the pathophysiologic response to severe burn injury

PLoS ONE

Volumn 6, Issue 7, 2011, Pages

  Jeschke, Marc G ^a,b,d   Gauglitz, Gerd G ^a,c   Kulp, Gabriela A ^a   Finnerty, Celeste C ^a,b   Williams, Felicia N ^a   Kraft, Robert ^a   Suman, Oscar E ^a,b   Mlcak, Ronald P ^a,b   Herndon, David N ^a,b  

^a UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^b University of Texas Medical Branch School of Medicine   (United States)

^c LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^d UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE PHASE PROTEIN; CATECHOLAMINE; HYDROCORTISONE; ADRENALIN; NORADRENALIN; PLASMA PROTEIN;

ACUTE PHASE RESPONSE; ARTICLE; BODY COMPOSITION; BODY SURFACE; BURN; BURN PATIENT; CATECHOLAMINE BLOOD LEVEL; CHILD; CLINICAL EXAMINATION; CONTROLLED STUDY; DEMOGRAPHY; DISEASE DURATION; ENERGY EXPENDITURE; FEMALE; HEART FUNCTION; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPERMETABOLISM; INFLAMMATION; INJURY SEVERITY; MAJOR CLINICAL STUDY; MALE; PATHOPHYSIOLOGY; PROTEIN BLOOD LEVEL; SCHOOL CHILD; CLINICAL TRIAL; ENZYMOLOGY; LIVER; METABOLISM; PATHOLOGY; TIME; URINE;

ACUTE-PHASE REACTION; BLOOD PROTEINS; BURNS; CHILD; DEMOGRAPHY; EPINEPHRINE; FEMALE; HUMANS; INFLAMMATION; LIVER; MALE; NOREPINEPHRINE; TIME FACTORS;

EID: 79960569443     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0021245     Document Type: Article

References (78)

1. Herndon DN, Tompkins RG, (2004) Support of the metabolic response to burn injury. Lancet 363: 1895-1902.
2. McCowen KC, Malhotra A, Bistrian BR, (2001) Stress-induced hyperglycemia. Crit Care Clin 17: 107-124.
3. Hart DW, Wolf SE, Mlcak R, Chinkes DL, Ramzy PI, et al. (2000) Persistence of muscle catabolism after severe burn. Surgery 128: 312-319.
4. Reiss E, Pearson E, Artz CP, (1956) The metabolic response to burns. J Clin Invest 35: 62-77.
5. Yu YM, Tompkins RG, Ryan CM, Young VR, (1999) The metabolic basis of the increase of the increase in energy expenditure in severely burned patients. JPEN J Parenter Enteral Nutr 23: 160-168.
6. Mlcak RP, Jeschke MG, Barrow RE, Herndon DN, (2006) The influence of age and gender on resting energy expenditure in severely burned children. Ann Surg 244: 121-130.
7. Przkora R, Barrow RE, Jeschke MG, Suman OE, Celis M, et al. (2006) Body composition changes with time in pediatric burn patients. J Trauma 60: 968-971.
8. Dolecek R, (1989) Endocrine changes after burn trauma-a review. Keio J Med 38: 262-276.
9. Jeffries MK, Vance ML, (1992) Growth hormone and cortisol secretion in patients with burn injury. J Burn Care Rehabil 13: 391-395.
10. Klein GL, Bi LX, Sherrard DJ, Beavan SR, Ireland D, et al. (2004) Evidence supporting a role of glucocorticoids in short-term bone loss in burned children. Osteoporos Int 15: 468-474.
11. Goodall M, Stone C, Haynes BW Jr, (1957) Urinary output of adrenaline and noradrenaline in severe thermal burns. Ann Surg 145: 479-487.
12. Coombes EJ, Batstone GF, (1982) Urine cortisol levels after burn injury. Burns Incl Therm Inj 8: 333-337.
13. Norbury WB, Herndon DN, (2007) Modulation of the hypermetabolic response after burn injury. In: Herndon DN, editors. Total Burn Care. 3rd ed New York Saunders Elsevier pp. 420-433.
14. Wolfe RR, (1981) Review: acute versus chronic response to burn injury. Circ Shock 8: 105-115.
15. Cuthbertson DP, Angeles Valero Zanuy MA, Leon Sanz ML, (2001) Post-shock metabolic response. 1942. Nutr Hosp 16: 176-182.
16. Pereira CT, Murphy KD, Herndon DN, (2005) Altering metabolism. J Burn Care Rehabil 26: 194-199.
17. Gauglitz GG, Herndon DN, Kulp GA, Meyer WJ 3rd, Jeschke MG, (2009) Abnormal insulin sensitivity persists up to three years in pediatric patients post-burn. J Clin Endocrinol Metab 94: 1656-1664.
18. Jeschke MG, Chinkes DL, Finnerty CC, Kulp G, Suman OE, et al. (2008) Pathophysiologic response to severe burn injury. Ann Surg 248: 387-401.
19. Jeschke MG, Micak RP, Finnerty CC, Herndon DN, (2007) Changes in liver function and size after a severe thermal injury. Shock 28: 172-177.
20. Williams FN, Jeschke MG, Chinkes DL, Suman OE, Branski LK, et al. (2009) Modulation of the hypermetabolic response to trauma: temperature, nutrition, and drugs. J Am Coll Surg 208: 489-502.
21. Jeschke MG, Mlcak RP, Finnerty CC, Norbury WB, Gauglitz GG, et al. (2007) Burn size determines the inflammatory and hypermetabolic response. Crit Care 11: R90.
22. Hart DW, Wolf SE, Chinkes DL, Gore DC, Mlcak RP, et al. (2000) Determinants of skeletal muscle catabolism after severe burn. Ann Surg 232: 455-465.
23. Sheridan RL, (2001) A great constitutional disturbance. N Engl J Med 345: 1271-1272.
24. Nyhlen K, Gautam C, Andersson R, Srinivas U, (2004) Modulation of cytokine-induced production of IL-8 in vitro by interferons and glucocorticosteroids. Inflammation 28: 77-88.
25. Fan J, Li YH, Wojnar MM, Lang CH, (1996) Endotoxin-induced alterations in insulin-stimulated phosphorylation of insulin receptor, IRS-1, and MAP kinase in skeletal muscle. Shock 6: 164-170.
26. del Aguila LF, Claffey KP, Kirwan JP, (1999) TNF-alpha impairs insulin signaling and insulin stimulation of glucose uptake in C2C12 muscle cells. Am J Physiol 276: E849-855.
27. Sell H, Dietze-Schroeder D, Kaiser U, Eckel J, (2006) Monocyte chemotactic protein-1 is a potential player in the negative cross-talk between adipose tissue and skeletal muscle. Endocrinology 147: 2458-2467.
28. McMurry JF Jr, (1984) Wound healing with diabetes mellitus. Better glucose control for better wound healing in diabetes. Surg Clin North Am 64: 769-778.
29. Mowlavi A, Andrews K, Milner S, Herndon DN, Heggers JP, (2000) The effects of hyperglycemia on skin graft survival in the burn patient. Ann Plast Surg 45: 629-632.
30. Gore DC, Chinkes DL, Hart DW, Wolf SE, Herndon DN, et al. (2002) Hyperglycemia exacerbates muscle protein catabolism in burn-injured patients. Crit Care Med 30: 2438-2442.
31. Guvener M, Pasaoglu I, Demircin M, Oc M, (2002) Perioperative hyperglycemia is a strong correlate of postoperative infection in type II diabetic patients after coronary artery bypass grafting. Endocr J 49: 531-537.
32. Gore DC, Chinkes D, Heggers J, Herndon DN, Wolf SE, et al. (2001) Association of hyperglycemia with increased mortality after severe burn injury. J Trauma 51: 540-544.
33. Thorell A, Efendic S, Gutniak M, Haggmark T, Ljungqvist O, (1993) Development of postoperative insulin resistance is associated with the magnitude of operation. Eur J Surg 159: 593-599.
34. Garcia-Avello A, Lorente JA, Cesar-Perez J, Garcia-Frade LJ, Alvarado R, et al. (1998) Degree of hypercoagulability and hyperfibrinolysis is related to organ failure and prognosis after burn trauma. Thromb Res 89: 59-64.
35. Christiansen C, Toft P, Jorgensen HS, Andersen SK, Tonnesen E, (2004) Hyperglycaemia and mortality in critically ill patients. A prospective study. Intensive Care Med 30: 1685-1688.
36. van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, et al. (2001) Intensive insulin therapy in the critically ill patients. N Engl J Med 345: 1359-1367.
37. Gore DC, Wolf SE, Herndon DN, Wolfe RR, (2003) Metformin blunts stress-induced hyperglycemia after thermal injury. J Trauma 54: 555-561.
38. Cree MG, Zwetsloot JJ, Herndon DN, Qian T, Morio B, et al. (2007) Insulin sensitivity and mitochondrial function are improved in children with burn injury during a randomized controlled trial of fenofibrate. Ann Surg 245: 214-221.
39. DeFronzo RA, Jacot E, Jequier E, Maeder E, Wahren J, et al. (1981) The effect of insulin on the disposal of intravenous glucose. Results from indirect calorimetry and hepatic and femoral venous catheterization. Diabetes 30: 1000-1007.
40. Saffle JR, Graves C, (2007) Nutritional support of the burned patient. In: Herndon DN, editors. Total Burn Care. 3rd ed London Saunders Elsevier pp. 398-419.
41. Rennie MJ, (1985) Muscle protein turnover and the wasting due to injury and disease. Br Med Bull 41: 257-264.
42. Biolo G, Fleming RY, Maggi SP, Wolfe RR, (1995) Transmembrane transport and intracellular kinetics of amino acids in human skeletal muscle. Am J Physiol 268: E75-E84.
43. Biolo G, Wolfe RR, (1994) Relationship between plasma amino acid kinetics and tissue protein synthesis and breakdown. Proc IFAC Symp on Modeling Control in Biol Systems pp. 358-359.
44. Chang DW, DeSanti L, Demling RH, (1998) Anticatabolic and anabolic strategies in critical illness: a review of current treatment modalities. Shock 10: 155-160.
45. Barret JP, Jeschke MG, Herndon DN, (2001) Fatty infiltration of the liver in severely burned pediatric patients: autopsy findings and clinical implications. J Trauma 51: 736-739.
46. Barrow RE, Hawkins HK, Aarsland A, Cox R, Rosenblatt J, et al. (2005) Identification of factors contributing to hepatomegaly in severely burned children. Shock 24: 523-528.
47. Jeschke MG, Low JF, Spies M, Vita R, Hawkins HK, et al. (2001) Cell proliferation, apoptosis, NF-kappaB expression, enzyme, protein, and weight changes in livers of burned rats. Am J Physiol Gastrointest Liver Physiol 280: G1314-1320.
48. Linares HA, (1988) Autopsy findings in burned children. In: Carvajal HF, Parks DH, editors. Burns in Children Chicago Year Book Medical Publishers.
49. Mittendorfer B, Jeschke MG, Wolf SE, Sidossis LS, (1998) Nutritional hepatic steatosis and mortality after burn injury in rats. Clin Nutr 17: 293-299.
50. Moshage H, (1997) Cytokines and the hepatic acute phase response. J Pathol 181: 257-266.
51. Vanhorebeek I, Langouche L, Van den Berghe G, (2006) Endocrine aspects of acute and prolonged critical illness. Nat Clin Pract Endocrinol Metab 2: 20-31.
52. Takagi K, Suzuki F, Barrow RE, Wolf SE, Herndon DN, (1998) Recombinant human growth hormone modulates Th1 and Th2 cytokine response in burned mice. Ann Surg 228: 106-111.
53. Takagi K, Suzuki F, Barrow RE, Wolf SE, Kobayashi M, et al. (1997) Growth hormone improves immune function and survival in burned mice infected with herpes simplex virus type 1. J Surg Res 69: 166-170.
54. Herndon DN, Hawkins HK, Nguyen TT, Pierre E, Cox R, et al. (1995) Characterization of growth hormone enhanced donor site healing in patients with large cutaneous burns. Ann Surg 221: 649-656.
55. Knox J, Demling R, Wilmore D, Sarraf P, Santos A, (1995) Increased survival after major thermal injury: the effect of growth hormone therapy in adults. J Trauma 39: 526-532.
56. Ponting GA, Halliday D, Teale JD, Sim AJ, (1988) Postoperative positive nitrogen balance with intravenous hyponutrition and growth hormone. Lancet 1: 438-440.
57. Voerman HJ, van Schijndel RJ, Groeneveld AB, de Boer H, Nauta JP, et al. (1992) Effects of recombinant human growth hormone in patients with severe sepsis. Ann Surg 216: 648-655.
58. Gore DC, Honeycutt D, Jahoor F, Wolfe RR, Herndon DN, (1991) Effect of exogenous growth hormone on whole-body and isolated-limb protein kinetics in burned patients. Arch Surg 126: 38-43.
59. Jeschke MG, Finnerty CC, Kulp GA, Przkora R, Mlcak RP, et al. (2008) Combination of recombinant human growth hormone and propranolol decreases hypermetabolism and inflammation in severely burned children. Pediatr Crit Care Med 9: 209-216.
60. Johnson TR, Rudin SD, Blossey BK, Ilan J, Ilan J, (1991) Newly synthesized RNA: simultaneous measurement in intact cells of transcription rates and RNA stability of insulin-like growth factor I, actin, and albumin in growth hormone-stimulated hepatocytes. Proc Natl Acad Sci U S A 88: 5287-5291.
61. Takala J, Ruokonen E, Webster NR, Nielsen MS, Zandstra DF, et al. (1999) Increased mortality associated with growth hormone treatment in critically ill adults. N Engl J Med 341: 785-792.
62. Debroy MA, Wolf SE, Zhang XJ, Chinkes DL, Ferrando AA, et al. (1999) Anabolic effects of insulin-like growth factor in combination with insulin-like growth factor binding protein-3 in severely burned adults. J Trauma 47: 904-911.
63. Herndon DN, Ramzy PI, Debroy MA, Zheng M, Ferrando AA, et al. (1999) Muscle protein catabolism after severe burn, effects of IGF-1/IGFBP3 treatment. Ann Surg 229: 713-720.
64. Jeschke MG, Barrow RE, Suzuki F, Rai J, Benjamin D, et al. (2002) IGF-I/IGFBP-3 equilibrates ratios of pro- to anti-inflammatory cytokines, which are predictors for organ function in severely burned pediatric patients. Mol Med 8: 238-246.
65. Klein GL, (2006) Burn-induced bone loss: Importance, mechanisms, and management. J Burns Wounds 5: e5.
66. Klein GL, Herndon DN, Langman CB, Rutan TC, Young WE, et al. (1995) Long-term reduction in bone mass after severe burn injury in children. J Pediatr 126: 252-256.
67. Klein GL, Herndon DN, Rutan TC, Sherrard DJ, Coburn JW, et al. (1993) Bone disease in burn patients. J Bone Miner Res 8: 337-345.
68. Klein GL, Kikuchi Y, Sherrard DJ, Simmons DJ, Biondo N, et al. (1996) Burn-associated bone disease in sheep: roles of immobilization and endogenous corticosteroids. J Burn Care Rehabil 17: 518-521.
69. Klein GL, Wimalawansa SJ, Kulkarni G, Sherrard DJ, Sanford AP, et al. (2005) The efficacy of acute administration of pamidronate on the conservation of bone mass following severe burn injury in children: a double-blind, randomized, controlled study. Osteoporos Int 16: 631-635.
70. Klein GL, Wolf SE, Goodman WG, Phillips WA, Herndon DN, (1997) The management of acute bone loss in severe catabolism due to burn injury. Horm Res 48 (Suppl 5): 83-87.
71. Hosking D, Chilvers CE, Christiansen C, Ravn P, Wasnich R, et al. (1998) Prevention of bone loss with alendronate in postmenopausal women under 60 years of age. Early Postmenopausal Intervention Cohort Study Group. N Engl J Med 338: 485-492.
72. Raab W, (1960) Key position of catecholamines in functional and degenerative cardiovascular pathology. Am J Cardiol 5: 571-578.
73. Pereira CT, Herndon DN, (2005) The pharmacologic modulation of the hypermetabolic response to burns. Adv Surg 39: 245-261.
74. Helm P, Herndon DN, Delateur B, (2007) Restoration of function. J Burn Care Res 28: 611-614.
75. Jeschke MG, Chinkes DL, Finnerty CC, Przkora R, Pereira CT, et al. (2007) Blood transfusions are associated with increased risk for development of sepsis in severely burned pediatric patients. Crit Care Med 35: 579-583.
76. Hamill PV, Drizd TA, Johnson CL, Reed RB, Roche AF, et al. (1979) Physical growth: National Center for Health Statistics percentiles. Am J Clin Nutr 32: 607-629.
77. Przkora R, Jeschke MG, Barrow RE, Suman OE, Meyer WJ, et al. (2005) Metabolic and hormonal changes of severely burned children receiving long-term oxandrolone treatment. Ann Surg 242: 384-391.
78. Jeschke MG, Finnerty CC, Suman OE, Kulp G, Mlcak RP, et al. (2007) The effect of oxandrolone on the endocrinologic, inflammatory, and hypermetabolic responses during the acute phase postburn. Ann Surg 246: 351-362.